These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10159110)

  • 1. Valuing health states: a comparison of methods.
    Dolan P; Gudex C; Kind P; Williams A
    J Health Econ; 1996 Apr; 15(2):209-31. PubMed ID: 10159110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values.
    Dolan P; Sutton M
    Soc Sci Med; 1997 May; 44(10):1519-30. PubMed ID: 9160441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing Child Health Utility 9D health states with a young adolescent sample: a feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods.
    Ratcliffe J; Couzner L; Flynn T; Sawyer M; Stevens K; Brazier J; Burgess L
    Appl Health Econ Health Policy; 2011; 9(1):15-27. PubMed ID: 21033766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.
    Matza LS; Boye KS; Feeny DH; Bowman L; Johnston JA; Stewart KD; McDaniel K; Jordan J
    Eur J Health Econ; 2016 Nov; 17(8):979-990. PubMed ID: 26611792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs.
    Bleichrodt H; Johannesson M
    J Health Econ; 1997 Apr; 16(2):155-75. PubMed ID: 10169092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time preference, duration and health state valuations.
    Dolan P; Gudex C
    Health Econ; 1995; 4(4):289-99. PubMed ID: 8528431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HYE (healthy years equivalent) and TTO (time trade-off): what is the difference?
    Morrison GC
    J Health Econ; 1997 Oct; 16(5):563-78. PubMed ID: 10175631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparability and reliability of five health-state valuation methods.
    Krabbe PF; Essink-Bot ML; Bonsel GJ
    Soc Sci Med; 1997 Dec; 45(11):1641-52. PubMed ID: 9428084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposal to solve the comparability problem in cost-utility analysis.
    Bleichrodt H; Herrero C; Pinto JL
    J Health Econ; 2002 May; 21(3):397-403. PubMed ID: 12022265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The time trade-off method: results from a general population study.
    Dolan P; Gudex C; Kind P; Williams A
    Health Econ; 1996; 5(2):141-54. PubMed ID: 8733106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.
    Guest JF; Nanuwa K; Barden R
    Health Qual Life Outcomes; 2014 Jun; 12():89. PubMed ID: 24917331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury.
    Lin MR; Yu WY; Wang SC
    Arch Phys Med Rehabil; 2012 Feb; 93(2):245-52. PubMed ID: 22289233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health values of patients with systemic sclerosis.
    Khanna D; Ahmed M; Furst DE; Ginsburg SS; Park GS; Hornung R; Tsevat J
    Arthritis Rheum; 2007 Feb; 57(1):86-93. PubMed ID: 17266070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated current health time-trade-off assessments in women's health.
    Tosteson AN; Kneeland TS; Nease RF; Sumner W
    Value Health; 2002; 5(2):98-105. PubMed ID: 11918825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A psychometric analysis of the measurement level of the rating scale, time trade-off, and standard gamble.
    Cook KF; Ashton CM; Byrne MM; Brody B; Geraci J; Giesler RB; Hanita M; Souchek J; Wray NP
    Soc Sci Med; 2001 Nov; 53(10):1275-85. PubMed ID: 11676400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Portuguese value set for the SF-6D.
    Ferreira LN; Ferreira PL; Pereira LN; Brazier J; Rowen D
    Value Health; 2010 Aug; 13(5):624-30. PubMed ID: 20230545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
    Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.